Haemonetics (HAE) Raw Materials (2011)

Haemonetics' (HAE) quarterly Raw Materials came in at $35.3 million in Q4 2011, up 16.35% quarter-over-quarter from $30.4 million in Q3 2011.

Haemonetics (HAE) Raw Materials (2011) Analysis & Trends

Haemonetics' Raw Materials history runs 1 years deep, the most recent figure standing at $35.3 million for Q4 2011.

On a quarterly basis, Raw Materials changed N/A year-over-year to $35.3 million in Q4 2011; TTM through Oct 2011 was $35.3 million, a N/A change from a year earlier, with the FY2011 full-year figure at $26.4 million, changed N/A from the prior year.
Raw Materials grew to $35.3 million in Q4 2011 per HAE's latest filing, from $30.4 million in the prior quarter.
Across five years, Raw Materials topped out at $35.3 million in Q4 2011 and bottomed at $26.4 million in Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Haemonetics	3.50 Bn	3.26 Bn	198.21 Mn

Download Data